ClinVar Miner

Submissions for variant NM_000329.3(RPE65):c.331C>A (p.Pro111Thr)

dbSNP: rs886042220
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen Leber Congenital Amaurosis/early Onset Retinal Dystrophy Variant Curation Expert Panel, ClinGen RCV003768999 SCV004697386 likely pathogenic RPE65-related recessive retinopathy 2024-01-31 reviewed by expert panel curation NM_000329.3(RPE65):c.331C>A is a missense variant encoding a substitution of proline by threonine at codon 111. The variant is located within the membrane-interacting region between amino acids 107 and 125, which is a well-characterized functional domain required for proper localization to the ER membrane (PM1, PMID: 36265895). Another missense variant in the same codon (NM_000329.3(RPE65):c.331C>T (p.Pro111Ser)) has been classified as likely pathogenic for RPE65-related recessive retinopathy by the ClinGen LCA / eoRD VCEP (PM5_Supporting, PMID: 32347917). Splicing prediction using SpliceAI did not strongly predict an effect on splicing due to either of these variants. The computational predictor REVEL gives a score of 0.968, which is above the ClinGen LCA / eoRD VCEP threshold of >= 0.773 for PP3_Moderate and predicts a damaging effect on RPE65 function (PP3_Moderate). This variant is absent from gnomAD v2.1.1 (PM2_Supporting). At least one proband harboring this variant exhibits a phenotype of retinal dystrophy, however, sufficient details are not available to establish specificity of phenotype for RPE65-related recessive retinopathy (SCV001240152.1). In summary, this variant meets the criteria to be classified as likely pathogenic for RPE65-related recessive retinopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen LCA/eoRP VCEP: PM1, PM2_Supporting, PM5_Supporting, PP3_Moderate. (VCEP specifications version 1.0.0; date of approval 09/21/2023).
Blueprint Genetics RCV001074561 SCV001240152 uncertain significance Retinal dystrophy 2018-12-18 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.